Skip to content
★ Sign in to follow
LG

Lewis Gary Davis

CFO
MusclePharm Corp
Total declarations
7
Company
1
▲ Purchases (5 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 05 Dec 2013 for MusclePharm Corp, €5,734.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Lewis Gary Davis: trading record in brief

Lewis Gary Davis is a declared insider of MusclePharm Corp, with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 16 November 2012 to 5 December 2013.

On the market, this insider has only ever bought: 5 purchases, €18k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. In 2013 alone, the filings show 5 purchases and no sales.

A typical purchase (the median) is worth €4,602.

The latest filing, published on 5 December 2013, reports an open-market purchase of €5,734 in MusclePharm Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Lewis Gary Davis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Chief Financial OfficerExecutivesMusclePharm Corp
    7,790 USD0SEC
    1,000 shares@ US$7.79Common StockSEC:0001144204-13-065822:0
    Canonical exit: 5 Mar 2014 (T+90)
  • ▲
    Chief Financial OfficerExecutivesMusclePharm Corp
    8,150 USD0SEC
    1,000 shares@ US$8.15Common StockSEC:0001144204-13-065822:1
    Canonical exit: 5 Mar 2014 (T+90)
  • ▲
    Chief Financial OfficerExecutivesMusclePharm Corp
    6,225 USD0SEC
    750 shares@ US$8.30Common StockSEC:0001144204-13-064453:0
    Canonical exit: 24 Feb 2014 (T+90)
  • ▲
    Chief Financial OfficerExecutivesMusclePharm Corp
    413 USD0SEC
    50 shares@ US$8.25Common StockSEC:0001144204-13-064453:1
    Canonical exit: 24 Feb 2014 (T+90)
  • ▲
    Chief Financial OfficerExecutivesMusclePharm Corp
    1,660 USD0SEC
    200 shares@ US$8.30Common StockSEC:0001144204-13-064453:2
    Canonical exit: 24 Feb 2014 (T+90)
  • ◆
    Chief Financial OfficerExecutivesMusclePharm Corp
    0SEC
    200,000 sharesRestricted Common StockSEC:0001144204-13-038572:0
  • ◆
    Chief Financial OfficerExecutivesMusclePharm Corp
    0SEC
    50,000,000 sharesCommon StockSEC:0001144204-12-064195:0

7 of 7 declarations